According to a new report, published by KBV research, The Global Tissue Diagnostics Market size is expected to reach $10.1 billion by 2030, rising at a market growth of 9.1% CAGR during the forecast period.
The Consumables segment is leading the Global Tissue Diagnostics Market by Product in 2022; thereby, achieving a market value of $6.4 billion by 2030. Demand for tissue diagnostics has increased due to several factors, including a rising consciousness regarding early disease detection, an aging population, and a greater incidence of chronic diseases. As diagnostic test volumes increase, there is a proportional rise in the consumption of consumables. Thus, these factors will boost the demand in the segment.
The In Situ Hybridization segment is experiencing a CAGR of 9.5% during (2023 - 2030). In situ hybridization allows for the precise localization of specific DNA or RNA sequences within tissue samples. This capability is crucial for molecular profiling, enabling the identification and visualization of genetic abnormalities, gene expression patterns, and specific biomarkers associated with diseases, especially in cancer diagnostics. Thus, these aspects will boost the demand in the segment.
The Breast Cancer segment is anticipating the Global Tissue Diagnostics Market by Disease Type in 2022; thereby, achieving a market value of $4.8 billion by 2030. Ongoing research in breast cancer has led to the identification of various molecular and genetic markers associated with the disease. Tissue diagnostics, including techniques such as immunohistochemistry (IHC) and in situ hybridization (ISH), are essential for profiling these markers, providing valuable information for treatment decision-making. Thus, these factors will help expand the segment.
The Research Laboratories segment would register a CAGR of 8.8% during (2023 - 2030). Research laboratories are instrumental in discovering and validating novel biomarkers associated with various diseases. These biomarkers are crucial for disease diagnosis, prognosis, and treatment response. Advances in genomics, transcriptomics, proteomics, and metabolomics within research labs contribute to identifying biomarkers with diagnostic and therapeutic potential. Therefore, these factors will assist in the expansion of the segment.
Full Report: https://www.kbvresearch.com/tissue-diagnostics-market/
The North America region dominated the Global Tissue Diagnostics Market by Region in 2022; thereby, achieving a market value of $4.1 billion by 2030. The Europe region is registering a CAGR of 8.7% during (2023 - 2030). Additionally, The Asia Pacific region would showcase a CAGR of 10% during (2023 - 2030).
By Product
By Technology
By Disease Type
By End User
By Geography
Unique Offerings 
